Global Smart Biopsy Devices Market, By Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Others), Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights of Smart Biopsy Devices Market
Data Bridge Market Research analyses that the smart biopsy devices market will exhibit a CAGR of around 6.12% for the forecast period of 2022-2029. Rising demand for minimally invasive surgical procedures, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced IT healthcare technologies, rising cases of cancer around the world and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of smart biopsy devices market.
Biopsy is a medical test that is used to cancer in the patients. Biopsy involves the surgical extraction of tissue for examination and diagnostic purposes. Smart biopsy devices are the medical devices that facilitate high quality differentiation of healthy cells and tumor cells.
Upsurge in the public-private funding for target research activities coupled with increased awareness about the advantages provided by the smart biopsy devices is one of the major factors fostering the growth of the market. Rising technological advancements and development in the field of robotics is another market growth determinant. Ever- rising technological advancement and innovation of new medical devices and instruments, increased number of product launches, growing support of the government for research activities, surging prevalence of breast cancer, unhealthy lifestyle of individuals, increasing cases of cervical cancer in women and increased government funding and untapped potential of the emerging markets will further generate lucrative market growth opportunities.
However, high costs associated with biopsy medical test and lack of skilled medical professionals will derail the market growth rate. Also, lack of awareness in the underdeveloped and backward economies and high expenditure required for research and development activities will further pose challenges for the market. High risk of infection and rising number of product recalls will further derail the market growth rate.
This smart biopsy devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on smart biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Smart Biopsy Devices Market Scope and Market Size
The smart biopsy devices market is segmented on the basis of application, product, guidance technique and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on application, the smart biopsy devices market is segmented into breast cancer, skin cancer, liver cancer, prostate cancer, and others.
- On the basis of product, the smart biopsy devices market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and other products. Needle-based biopsy instruments are further segmented into core biopsy devices, aspiration biopsy needles, vacuum-assisted biopsy devices, localization wires, procedure trays, and others. Core biopsy devices are further sub-segmented into core biopsy guns and core biopsy needles. Vacuum-assisted biopsy devices are further sub-segmented into vacuum-assisted biopsy systems and vacuum-assisted biopsy needles.
- On the basis of guidance technique, the smart biopsy devices market is segmented into ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging-guided biopsy, and other guidance techniques.
- On the basis of end user, the smart biopsy devices market is segmented into hospitals, academic and research institutes, and diagnostic and imaging centers.
Smart Biopsy Devices Market Country Level Analysis
The smart biopsy devices market is segmented on the basis of application, product, guidance technique and end-user.
The countries covered in the smart biopsy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the smart biopsy devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies and presence of major players in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the increasing government expenditure on healthcare sector and increasing cases of breast cancer in the region.
The country section of the smart biopsy devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The smart biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for smart biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the smart biopsy devices market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Smart Biopsy Devices Market Share Analysis
The smart biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to smart biopsy devices market.
Some of the major players operating in the smart biopsy devices market report are BD, Cook, Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, Scion Medical Technologies, LLC, UROMED Kurt Drews KG, STERYLAB S.r.l., DTR Medical Ltd, EndoMed Systems Alle Rechte vorbehalten., CONMED Corporation, TSK Laboratory Europe B.V., ZAMAR CARE, B. Braun Melsungen AG, Cardinal Health, Siemens, General Electric Company, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Olympus Corporation, Medtronic, and SRL Diagnostics among others.
SKU-